Variant report
Variant | nsv969924 |
---|---|
Chromosome Location | chr5:50330458-50333233 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs150068395 | chr5:50330466-50330467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs188810824 | chr5:50330487-50330488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557893862 | chr5:50330490-50330491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs577477094 | chr5:50330503-50330504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs550008018 | chr5:50330518-50330519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs374289966 | chr5:50330528-50330529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs191044046 | chr5:50330559-50330560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs145404474 | chr5:50330565-50330566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs112548802 | chr5:50330571-50330572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs199771268 | chr5:50330583-50330584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576657260 | chr5:50330627-50330628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs542559746 | chr5:50330630-50330631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs183218890 | chr5:50330654-50330655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs527691109 | chr5:50330667-50330668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs541093684 | chr5:50330732-50330733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187468204 | chr5:50330763-50330764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs116149020 | chr5:50330787-50330788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549694298 | chr5:50330791-50330792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs192017537 | chr5:50330870-50330871 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs115201978 | chr5:50330895-50330896 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs140150670 | chr5:50330919-50330920 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs565636654 | chr5:50330976-50330977 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs534615000 | chr5:50330979-50330980 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557855208 | chr5:50331049-50331050 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs184827412 | chr5:50331055-50331056 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs74737645 | chr5:50331116-50331117 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567696284 | chr5:50331155-50331156 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs534602081 | chr5:50331156-50331157 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188088504 | chr5:50331246-50331247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs576583419 | chr5:50331287-50331288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192369745 | chr5:50331295-50331296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs116619282 | chr5:50331365-50331366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs554204822 | chr5:50331392-50331393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs184653518 | chr5:50331397-50331398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs572382153 | chr5:50331421-50331422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs540412456 | chr5:50331526-50331527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs200921271 | chr5:50331534-50331535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs188280800 | chr5:50331584-50331585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs182013891 | chr5:50331630-50331631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs184856700 | chr5:50331686-50331687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs543943019 | chr5:50331715-50331716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs189136314 | chr5:50331728-50331729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529095292 | chr5:50331752-50331753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs576339358 | chr5:50331814-50331815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs181699451 | chr5:50331816-50331817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs566000496 | chr5:50331887-50331888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs143758088 | chr5:50331902-50331903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs561967535 | chr5:50332006-50332007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs551377736 | chr5:50332022-50332023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs571313697 | chr5:50332076-50332077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21364760 | CNVD |
Oral cancer | 21386901 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:50330200-50330800 | Enhancers | Stomach Mucosa | stomach |
2 | chr5:50330200-50331200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
3 | chr5:50330400-50330800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr5:50330800-50334200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr5:50331000-50331200 | Enhancers | Liver | Liver |